Skip to main content
Camurus logo

Camurus — Investor Relations & Filings

Ticker · CAMX ISIN · SE0007692850 LEI · 5493003S6Z6VI7WYFQ06 ST Manufacturing
Filings indexed 383 across all filing types
Latest filing 2026-05-28 Transaction in Own Shar…
Country SE Sweden
Listing ST CAMX

About Camurus

https://www.camurus.com/

Camurus is a science-led biopharmaceutical company that develops and commercializes innovative, long-acting medicines for severe and chronic diseases. The company specializes in advanced drug delivery systems designed to improve treatment outcomes, enhance patient quality of life, and provide value to society. Its therapeutic focus areas include opioid dependence, cancer and supportive care, endocrine conditions, rare diseases, and disorders of the central nervous system. Camurus maintains a diversified research and development pipeline to address significant unmet medical needs.

Recent filings

Filing Released Lang Actions
Camurus’ Board of Directors exercises authorization for repurchase of shares for the purpose of securing the company’s commitments under the Performance Share Plan 2026/2029
Transaction in Own Shares Classification · 90% confidence The document is a press release by the company’s Board of Directors announcing and detailing the repurchase of its own Series C shares under an existing authorization, including repurchase price and timing. This constitutes a transaction in own shares and is therefore classified under code POS.
2026-05-28 English
Camurus styrelse utnyttjar återköpsbemyndigande för säkerställande av bolagets åtaganden enligt Prestationsaktieprogram 2026/2029
Share Issue/Capital Change Classification · 88% confidence The document is a press release announcing a directed new issue of up to 570,000 convertible C-shares and the board’s repurchase of these C-shares under an existing authorization, followed by conversion into ordinary shares. These actions constitute a corporate capital change (new share issuance and repurchase). Therefore, it falls under Share Issue/Capital Change (SHA).
2026-05-28 Swedish
Resolutions at the annual general meeting 2026 in Camurus
Declaration of Voting Results & Voting Rights Announcements Classification · 80% confidence The document is a press release summarizing the resolutions adopted at Camurus AB’s 2026 Annual General Meeting, including election of board members, fees, dividend appropriation, authorizations for share issues/buybacks, and approval of a performance share plan. It constitutes an official declaration of shareholder vote outcomes at an AGM. Therefore, it falls under Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-28 English
Beslut vid Camurus årsstämma 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a press release summarizing the resolutions adopted at the company’s 2026 Annual General Meeting, including election of board members, approval of remuneration, disposition of profits, and share authorization decisions. It provides official shareholder vote outcomes at the AGM. This matches the “Declaration of Voting Results & Voting Rights Announcements” category.
2026-05-28 Swedish
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 95% confidence The document is titled “Delårsrapport Första kvartalet 2026” and provides detailed financial results, metrics and analysis for Q1 2026, including revenue, operating profit, net cash, segment analysis, tables of figures, and narrative commentary. It is a comprehensive interim/quarterly financial report rather than a brief earnings release or announcement of publication. Therefore, it matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-12 Swedish
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 92% confidence The document is clearly labelled “INTERIM REPORT FOR THE FIRST QUARTER 2026” and contains detailed quarter-to-quarter and year-to-date financial tables, P&L metrics, narrative business review, outlook commentary, and operational highlights. It provides substantive financial data and analysis for a period shorter than a full fiscal year, matching the definition of an Interim/Quarterly Report. Q1 2026
2026-05-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.